George Small, MD, an adult neurologist at Allegheny Health Network, provided an overview on the state of care for patients with MG, and the integration of new therapeutics. He stressed the vast improvement in adverse event profiles with these agents, as well as how over time, the growing amount of data on MG has helped pave the way its treated today.
([ Ссылка ])
More Content:
-Assessing Treatment Decisions for Myasthenia Gravis ([ Ссылка ])
-The Improved State of Myasthenia Gravis Care ([ Ссылка ])
-A New Era of Myasthenia Gravis Treatment ([ Ссылка ])
